Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calyxt/PBL deal on wheat trait

The US subsidiary of French genomics company Cellectis, Calyxt (New Brighton, Minnesota), has entered an exclusive licensing agreement with UK early-stage investment company Plant Bioscience (PBL - Norwich, UK) for a bread wheat trait generated using gene editing. The trait provides endogenous resistance to powdery mildew of wheat (Blumeria graminis f sp tritici). “As part of our product development strategy, we are now in-licensing traits developed by world class academic institutions to boost our pipeline of products in various crops,” says Calyxt chief executive officer Luc Mathis. PBL is jointly owned by the UK John Innes Centre, the Sainsbury Laboratory and the Biotechnology and Biological Sciences Research Council (BBSRC). Calyxt is the new name given to Cellectis Plant Sciences in May.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022749

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel